SS Innovations International (SSII) Cash from Financing Activities (2016 - 2026)
SS Innovations International (SSII) reported Cash from Financing Activities of $18.2 million for Q1 2026, down 18.95% on a YoY basis from $22.4 million in Q1 2025, and up 1222.47% sequentially from $1.4 million in Q4 2025.
SS Innovations International (SSII) Cash from Financing Activities (2016 - 2026) Analysis & Trends
SS Innovations International (SSII) has 11 years of Cash from Financing Activities data on file, last reported at $18.2 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities fell 18.95% year-over-year to $18.2 million; the trailing twelve-month figure through Mar 2026 stood at $21.9 million (down 24.91% YoY), and the FY2025 full-year result was $26.2 million, up 177.6% from the prior year.
- Cash from Financing Activities climbed to $18.2 million in Q1 2026, from $1.4 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $22.4 million in Q1 2025 to a low of -$702098.0 in Q2 2025.
- A 5-year average of $5.4 million and a median of $2.7 million in 2024 frame the typical range for Cash from Financing Activities.
- Across the five-year window, Cash from Financing Activities surged 15516.71% in 2022 and tumbled 126.45% in 2025, its largest moves.
- Tracing SSII's Cash from Financing Activities over 5 years: stood at $3.1 million in 2022, then tumbled by 95.1% to $150563.0 in 2023, then soared by 2165.52% to $3.4 million in 2024, then tumbled by 59.74% to $1.4 million in 2025, then soared by 1222.47% to $18.2 million in 2026.
- Business Quant data shows SSII's Cash from Financing Activities at $18.2 million in Q1 2026, $1.4 million in Q4 2025, and $3.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -25.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -26.93 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | SS Innovations International | 699.75 Mn | 676.14 Mn | 5.33 Mn | 18.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.16 Mn |
| Mar 31, 2026 | 18.16 Mn |
| Dec 31, 2025 | 1.37 Mn |
| Dec 31, 2025 | 1.37 Mn |
| Sep 30, 2025 | 3.09 Mn |
| Sep 30, 2025 | 3.09 Mn |
| Jun 30, 2025 | -702,098.00 |
| Jun 30, 2025 | -702,098.00 |
| Mar 31, 2025 | 22.41 Mn |
| Mar 31, 2025 | 22.41 Mn |
| Dec 31, 2024 | 3.41 Mn |
| Dec 31, 2024 | 3.41 Mn |
| Sep 30, 2024 | 722,336.00 |
| Sep 30, 2024 | 722,336.00 |
| Jun 30, 2024 | 2.65 Mn |
| Jun 30, 2024 | 2.65 Mn |
| Mar 31, 2024 | 2.64 Mn |
| Mar 31, 2024 | 2.64 Mn |
| Dec 31, 2023 | 150,563.00 |
| Dec 31, 2023 | 150,563.00 |